NOTE: Many features on this website require Javascript and cookies. You can enable both via your browser's preference settings.
MNTderm - 18/03/2012 07:00:00
A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine...
Sign in or register to comment on this story